Evidence-Based Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea: 2025 Revised Edition
Authors:
- Chang Seok BangChang Seok Bang
- Seung Joo KangSKSeung Joo Kang
- Hyunchul LimHLHyunchul Lim
- Seung Han KimSKSeung Han Kim
- Moon Won LeeMLMoon Won Lee
- Su Youn NamSNSu Youn Nam
- Chung Hyun TaeCTChung Hyun Tae
- Sung Eun KimSKSung Eun Kim
- Seung Young KimSKSeung Young Kim
- Hye-Kyung JungHJHye-Kyung Jung
- Beom Jin KimBKBeom Jin Kim
- Miyoung ChoiMCMiyoung Choi
Open Access
- 10 June 2026
- journal article
- review article
- Published by Korean College of Helicobacter and Upper Gastrointestinal Research in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
- Vol. 26 (2) , 164-188
Abstract
Evidence-Based Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea: 2025 Revised EditionKeywords
Funding Information
- Patient-Centered Clinical Research Coordinating Center
- Ministry of Health and Welfare (RS-2025-02304642)
This publication has 177 references indexed in Scilit:
- Concomitant versus reverse hybrid therapy for eradication of Helicobacter pylori infection—An open-label randomized controlled trialIndian Journal of Gastroenterology, 2025
- Vonoprazan: A Review in Helicobacter pylori InfectionDrugs, 2024
- Treatment of Helicobacter pylori infection 14‐day concomitant quadruple therapy versus triple therapy: A parallel double‐blind randomized controlled trialHealth Science Reports, 2023
- Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled studyJournal of Gastroenterology, 2023
- Minocycline vs. tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trialJournal of Gastroenterology, 2023
- Ten-day concomitant and sequential therapy for Helicobacter pylori effective in region with high antibiotic resistance ratesIndian Journal of Gastroenterology, 2022
- Cost-Effectiveness of Empirical Bismuth-Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori EradicationDigestive Diseases and Sciences, 2021
- Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled TrialDigestive Diseases and Sciences, 2020
- Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trialIndian Journal of Gastroenterology, 2019
- Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of ChinaJAMA, 2004